Jennifer McNealey
Directeur/Bestuurslid bij ANTIBE THERAPEUTICS INC.
Vermogen: 5 441 $ op 30-04-2024
Profiel
Jennifer Isacoff McNealey is the founder of Laurient LLC, which was founded in 2005.
She is currently an Independent Director at Antibe Therapeutics, Inc. and Conduit Pharmaceuticals, Inc. She is also the Chief Financial Officer at Abdera Therapeutics, Inc. Jennifer's former jobs include being an Independent Director at Enzon Pharmaceuticals, Inc. from 2013 to 2021, Senior Director-Investor Relations at Calithera Biosciences, Inc. from 2015 to 2016, Analyst at Amerindo Investment Advisors, Inc., Portfolio Manager at Paramount Capital, Inc., Analyst at Franklin Advisers, Inc., Research Analyst at Weiss, Peck & Greer LLC, and Portfolio Manager at Morgan Stanley Dean Witter Advisors, Inc. She was also the Chief Financial Officer at Telesis Bio, Inc. from 2015 to 2022.
Jennifer received her undergraduate and graduate degrees from Cornell University in 1995 and 1997, respectively.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
11-01-2024 | 38 334 ( 0.07% ) | 5 441 $ | 30-04-2024 |
Actieve functies van Jennifer McNealey
Bedrijven | Functie | Begin |
---|---|---|
ANTIBE THERAPEUTICS INC. | Directeur/Bestuurslid | 24-11-2020 |
CONDUIT PHARMACEUTICALS INC. | Directeur/Bestuurslid | 22-09-2023 |
Abdera Therapeutics, Inc.
Abdera Therapeutics, Inc. BiotechnologyHealth Technology Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes. | Financieel Directeur/CFO | - |
Eerdere bekende functies van Jennifer McNealey
Bedrijven | Functie | Einde |
---|---|---|
TELESIS BIO, INC. | Financieel Directeur/CFO | 08-07-2022 |
ENZON PHARMACEUTICALS, INC. | Directeur/Bestuurslid | 01-11-2021 |
Laurient LLC | Oprichter | 01-01-2012 |
Franklin Advisers, Inc.
Franklin Advisers, Inc. Investment ManagersFinance Franklin Advisers, Inc. is a mutual fund manager and registered investment advisor headquartered in San Mateo, California. The firm was founded in 1985 and is a subsidiary of Franklin Resources, Inc. (NYSE: BEN), a holding company that, together with its various subsidiaries is referred to as Franklin Templeton Investments. Franklin Advisers provides investment advisory and portfolio management services to US and non-US, registered open-end and closed-end funds and unregistered funds, as well as separate accounts. | Analyst-Equity | 01-08-2005 |
Morgan Stanley Dean Witter Advisors, Inc. | Corporate Officer/Principal | - |
Opleiding van Jennifer McNealey
Cornell University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 5 |
---|---|
ENZON PHARMACEUTICALS, INC. | Health Technology |
CALITHERA BIOSCIENCES, INC. | Health Technology |
ANTIBE THERAPEUTICS INC. | Health Technology |
TELESIS BIO, INC. | Commercial Services |
CONDUIT PHARMACEUTICALS INC. | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Franklin Advisers, Inc.
Franklin Advisers, Inc. Investment ManagersFinance Franklin Advisers, Inc. is a mutual fund manager and registered investment advisor headquartered in San Mateo, California. The firm was founded in 1985 and is a subsidiary of Franklin Resources, Inc. (NYSE: BEN), a holding company that, together with its various subsidiaries is referred to as Franklin Templeton Investments. Franklin Advisers provides investment advisory and portfolio management services to US and non-US, registered open-end and closed-end funds and unregistered funds, as well as separate accounts. | Finance |
Weiss, Peck & Greer LLC | Finance |
Amerindo Investment Advisors, Inc.
Amerindo Investment Advisors, Inc. Investment ManagersFinance Amerindo Investment Advisors Inc. is a San Francisco-based firm that manages institutional portfolios having a focus on Internet and Internet related issuers. The firm's separate account business consists of corporate ERISA plans, public pension plans, endowments, foundations, family trusts and high net worth individuals. Amerindo mutual funds are offered for the investor seeking a concentration in emerging technology with a focus on the Internet, health sciences and biotechnology. | Finance |
Laurient LLC | |
Paramount Capital, Inc. | |
Morgan Stanley Dean Witter Advisors, Inc. | |
Abdera Therapeutics, Inc.
Abdera Therapeutics, Inc. BiotechnologyHealth Technology Abdera Therapeutics, Inc. is a Canadian precision oncology company that operates in the field of cancer treatment. The CEO of the company is Lana Elizabeth Janes. | Health Technology |